Trade Summary

Yesterday, ROTHBLATT MARTINE A, serving as Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $551.13 per share, for a total transaction value of $5,235,756.07. Following this transaction, ROTHBLATT MARTINE A now holds 40,513 shares of UTHR.

This sale represents a 19.00% decrease in ROTHBLATT MARTINE A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, July 9, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 10, 2026 (accepted Jul 9, 9:26 PM ET), 1 day after the trade was made.

UNITED THERAPEUTICS Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.